Patient-derived organoids: Are PDOs the new PDX?

    loading  Checking for direct PDF access through Ovid

Abstract

Patient-derived organoids in pancreatic cancer maintain genotypic, transcriptomic, and potentially phenotypic responses to chemotherapy of the primary tumor.

Related Topics

    loading  Loading Related Articles